CDC and FDA Recommend Resuming Use of J&J COVID-19 Vaccine

After reviewing the data, the CDC and FDA recommend resuming the use of Johnson & Johnson’s Janssen (J&J) COVID-19 vaccine citing confidence in both the safety and efficacy of the vaccine. Munson Healthcare is exploring the best use cases for our small quantity of J&J vaccine doses.

For more information (also available on our COVID-19 vaccine webpage):

• Janssen Vaccine Information Sheet

• Fact Sheet for Recipients and Caregivers
• ACIP Meeting Notes: Resuming use of Janssen Vaccine
• 4.27.21 COCA Call